These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35322671)

  • 1. Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations.
    Olmastroni E; Gazzotti M; Arca M; Averna M; Pirillo A; Catapano AL; Casula M;
    J Am Heart Assoc; 2022 Apr; 11(7):e023668. PubMed ID: 35322671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.
    Sharifi M; Higginson E; Bos S; Gallivan A; Harvey D; Li KW; Abeysekera A; Haddon A; Ashby H; Shipman KE; Cooper JA; Futema M; Roeters van Lennep JE; Sijbrands EJG; Labib M; Nair D; Humphries SE
    Atherosclerosis; 2017 Aug; 263():405-411. PubMed ID: 28549500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia.
    Olmastroni E; Gazzotti M; Averna M; Arca M; Tarugi P; Calandra S; Bertolini S; Catapano AL; Casula M;
    J Am Heart Assoc; 2023 May; 12(10):e029223. PubMed ID: 37183858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries.
    Futema M; Shah S; Cooper JA; Li K; Whittall RA; Sharifi M; Goldberg O; Drogari E; Mollaki V; Wiegman A; Defesche J; D'Agostino MN; D'Angelo A; Rubba P; Fortunato G; Waluś-Miarka M; Hegele RA; Aderayo Bamimore M; Durst R; Leitersdorf E; Mulder MT; Roeters van Lennep JE; Sijbrands EJ; Whittaker JC; Talmud PJ; Humphries SE
    Clin Chem; 2015 Jan; 61(1):231-8. PubMed ID: 25414277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia.
    Trinder M; Paquette M; Cermakova L; Ban MR; Hegele RA; Baass A; Brunham LR
    Circ Genom Precis Med; 2020 Oct; 13(5):515-523. PubMed ID: 33079599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
    Amor-Salamanca A; Castillo S; Gonzalez-Vioque E; Dominguez F; Quintana L; Lluís-Ganella C; Escudier JM; Ortega J; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    J Am Coll Cardiol; 2017 Oct; 70(14):1732-1740. PubMed ID: 28958330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of 12-SNP and 6-SNP Polygenic Scores on Predisposition to High LDL-Cholesterol Levels in Patients with Familial Hypercholesterolemia.
    Cardiero G; Ferrandino M; Calcaterra IL; Iannuzzo G; Di Minno MND; Buganza R; Guardamagna O; Auricchio R; Di Taranto MD; Fortunato G
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia.
    Trinder M; Cermakova L; Ruel I; Baass A; Paquette M; Wang J; Kennedy BA; Hegele RA; Genest J; Brunham LR
    Arterioscler Thromb Vasc Biol; 2024 Jul; 44(7):1683-1693. PubMed ID: 38779854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetics of familial hypercholesterolemia in Israel-revisited.
    Durst R; Ibe UK; Shpitzen S; Schurr D; Eliav O; Futema M; Whittall R; Szalat A; Meiner V; Knobler H; Gavish D; Henkin Y; Ellis A; Rubinstein A; Harats D; Bitzur R; Hershkovitz B; Humphries SE; Leitersdorf E
    Atherosclerosis; 2017 Feb; 257():55-63. PubMed ID: 28104544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation spectrum and polygenic score in German patients with familial hypercholesterolemia.
    Rieck L; Bardey F; Grenkowitz T; Bertram L; Helmuth J; Mischung C; Spranger J; Steinhagen-Thiessen E; Bobbert T; Kassner U; Demuth I
    Clin Genet; 2020 Nov; 98(5):457-467. PubMed ID: 32770674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia.
    Futema M; Bourbon M; Williams M; Humphries SE
    Atherosclerosis; 2018 Oct; 277():457-463. PubMed ID: 30270085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of polygenic cause in Korean patients with familial hypercholesterolemia - A study supported by Korean Society of Lipidology and Atherosclerosis.
    Kwon M; Han SM; Kim DI; Rhee MY; Lee BK; Ahn YK; Cho BR; Woo J; Hur SH; Jeong JO; Jang Y; Lee SH; Lee JH
    Atherosclerosis; 2015 Sep; 242(1):8-12. PubMed ID: 26160041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygenic risk scores for low-density lipoprotein cholesterol and familial hypercholesterolemia.
    Nomura A; Sato T; Tada H; Kannon T; Hosomichi K; Tsujiguchi H; Nakamura H; Takamura M; Tajima A; Kawashiri MA
    J Hum Genet; 2021 Nov; 66(11):1079-1087. PubMed ID: 33967275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polygenic contribution for familial hypercholesterolemia (FH).
    Medeiros AM; Bourbon M
    Curr Opin Lipidol; 2021 Dec; 32(6):392-395. PubMed ID: 34751168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease.
    Tada H; Kawashiri MA; Nomura A; Teramoto R; Hosomichi K; Nohara A; Inazu A; Mabuchi H; Tajima A; Yamagishi M
    J Clin Lipidol; 2018; 12(6):1436-1444. PubMed ID: 30241732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of practical applicability and clinical relevance of a commonly used LDL-C polygenic score in patients with severe hypercholesterolemia.
    Tromp TR; Cupido AJ; Reeskamp LF; Stroes ESG; Hovingh GK; Defesche JC; Schmidt AF; Zuurbier L
    Atherosclerosis; 2022 Jan; 340():61-67. PubMed ID: 34774301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Children and Adolescents with Familial Hypercholesterolemia.
    Minicocci I; Pozzessere S; Prisco C; Montali A; di Costanzo A; Martino E; Martino F; Arca M
    J Pediatr; 2017 Apr; 183():100-107.e3. PubMed ID: 28161202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of clinical and laboratory parameters used in the identification of index cases for genetic screening of familial hypercholesterolemia in Brazil.
    Silva PRS; Jannes CE; Oliveira TGM; Miname MH; Rocha VZ; Chacra AP; Gurgel MHC; Montenegro RM; Rodrigues Sobrinho CRM; Bello Moreira AS; Assad MHV; Pinto MRC; Tada MT; Santos RD; Pereira AC; Krieger JE
    Atherosclerosis; 2017 Aug; 263():257-262. PubMed ID: 28689098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia.
    Trinder M; Li X; DeCastro ML; Cermakova L; Sadananda S; Jackson LM; Azizi H; Mancini GBJ; Francis GA; Frohlich J; Brunham LR
    J Am Coll Cardiol; 2019 Jul; 74(4):512-522. PubMed ID: 31345425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.